AIMC Topic: Randomized Controlled Trials as Topic

Clear Filters Showing 291 to 300 of 348 articles

Transformer-Based Language Models for Group Randomized Trial Classification in Biomedical Literature: Model Development and Validation.

JMIR medical informatics
BACKGROUND: For the public health community, monitoring recently published articles is crucial for staying informed about the latest research developments. However, identifying publications about studies with specific research designs from the extens...

Concordance with SPIRIT-AI guidelines in reporting of randomized controlled trial protocols investigating artificial intelligence in oncology: a systematic review.

The oncologist
BACKGROUND: Artificial intelligence (AI) is a promising tool used in oncology that may be able to facilitate diagnosis, treatment planning, and patient management. Transparency and completeness of protocols of randomized controlled trials (RCT) invol...

Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH.

Journal of hepatology
BACKGROUND & AIMS: Intra and inter-pathologist variability poses a significant challenge in metabolic dysfunction-associated steatohepatitis (MASH) biopsy evaluation, leading to suboptimal selection of patients and confounded assessment of histologic...

Using Machine Learning to Predict Uptake to an Online Self-Guided Intervention for Stress During the COVID-19 Pandemic.

Stress and health : journal of the International Society for the Investigation of Stress
Online self-guided interventions appear efficacious for alleviating some mental health concerns. However, among persons who are offered online interventions, only a fraction access them (i.e., achieve uptake). Machine learning methods may be useful t...

Deep learning for electrocardiogram interpretation: Bench to bedside.

European journal of clinical investigation
BACKGROUND: Recent advancements in deep learning (DL), a subset of artificial intelligence, have shown the potential to automate and improve disease recognition, phenotyping and prediction of disease onset and outcomes by analysing various sources of...

Predicting Postoperative Circulatory Complications in Older Patients: A Machine Learning Approach.

Biomedical and environmental sciences : BES
OBJECTIVE: This study examines utilizes the advantages of machine learning algorithms to discern key determinants in prognosticate postoperative circulatory complications (PCCs) for older patients.

Effect of artificial intelligence driven therapeutic lifestyle changes (AI-TLC) intervention on health behavior and health among obesity pregnant women in China: a randomized controlled trial protocol.

Frontiers in public health
INTRODUCTION: Obesity has reached epidemic proportions globally, posing significant challenges to public health and economic stability. In China, the prevalence of obesity is increasing rapidly, particularly among pregnant women, who face unique risk...

Comparison of Different Machine Learning Methodologies for Predicting the Non-Specific Treatment Response in Placebo Controlled Major Depressive Disorder Clinical Trials.

Clinical and translational science
Placebo effect represents a serious confounder for the assessment of treatment effect to the extent that it has become increasingly difficult to develop antidepressant medications appropriate for outperforming placebo. Treatment effect in randomized,...

The 'golden fleece of embryology' eludes us once again: a recent RCT using artificial intelligence reveals again that blastocyst morphology remains the standard to beat.

Human reproduction (Oxford, England)
Grading of blastocyst morphology is used routinely for embryo selection with good outcomes. A lot of effort has been placed in IVF to search for the prize of selecting the most viable embryo to transfer ('the golden fleece of embryology'). To improve...

Artificial Intelligence in Cardiovascular Clinical Trials.

Journal of the American College of Cardiology
Randomized clinical trials are the gold standard for establishing the efficacy and safety of cardiovascular therapies. However, current pivotal trials are expensive, lengthy, and insufficiently diverse. Emerging artificial intelligence (AI) technolog...